Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Cormedix Inc.

Headquarters: Berkeley Heights , NJ, United States of America
Year Founded: 2006
Status: Public
Industry Sector: HealthTechnology
CEO: Joseph Todisco, MBA
Number Of Employees: 82
Enterprise Value: $115,954,568
PE Ratio: -12.95
Exchange/Ticker 1: NASDAQ:CRMD
Exchange/Ticker 2: N/A
Latest Market Cap: $629,829,312

BioCentury | Dec 16, 2023
Management Tracks

Mistras, Martin join Viatris

Plus: Nassim Usman at the helm at Totus as it raises $66M series B round, and updates from Tourmaline, HKEX, CIRM, CorMedix and RiverVest
BioCentury | Nov 16, 2023
Deals

Nov. 15 Quick Takes: Kite, Arcellx expand CAR T deal 

Plus: Gilde closes new €740M fund and updates from RefleXion, NMD, Lenz-Graphite, Cytovale, T-Therapeutics, Vittoria, CorMedix
BioCentury | May 13, 2022
Management Tracks

New CEOs at CorMedix, Medigene

Plus updates from Elicio, Rejuvenate, Canbridge and more
BioCentury | Mar 18, 2022
Management Tracks

Jha replaces Zients as COVID response coordinator

Plus games vet Jon David joins Akili, and updates from CorMedix and Seer
BioCentury | Oct 5, 2021
Management Tracks

Medicxi’s Grainger joins Centessa as chief innovation officer

Plus: Certara, MOMA, Quotient, Mogrify, Acadia, CorMedix and more
BioCentury | May 17, 2021
Management Tracks

Tousi promoted to chief commercial officer at Illumina; plus Kintor, Esperion, AffaMed, Escient and more

Susan Tousi was promoted to chief commercial officer at Illumina Inc. (NASDAQ:ILMN). Tousi joined the genome sequencing company in 2012 as VP of engineering, and was most recently SVP and chief
BioCentury | Jul 18, 2015
Company News

Management tracks

BioCentury | May 11, 2015
Analyst Picks & Changes

Analyst picks & changes

Items per page:
1 - 10 of 50